Skip to content
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
Intranet
Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis
02/09/2022
Manda G, Milanesi E, Genc S, Niculite CM, Neagoe IV, Tastan B, Dragnea EM, Cuadrado A
By: Manda G, Milanesi E, Genc S, Niculite CM, Neagoe IV, Tastan B, Dragnea EM, Cuadrado A
Go to publication
